Loading data for CDXS — first visit, this takes a few seconds.
Codexis Inc. (CDXS)
NasdaqGS: CDXS
· Real-Time Price · USD
1.66
+0.01 (0.61%)
At close: Aug 28, 2026, 8:00 PM
1.61
+1.26%
After-hours: 7:30 PM
The price, the headline numbers and the latest news, in one place.
Codexis Inc. (CDXS) Stock Price, Analysis & Data
0.61% (1D)
No data available
| Bid | 1.19 |
| Market Cap | 174.11M |
| Revenue (ttm) | 77.68M |
| Net Income (ttm) | -30.72M |
| 2.50 | |
| -0.33 | |
| n/a | |
| -4.97 | |
| P/B (ttm) | 4.40 |
| P/S (ttm) | 2.24 |
| Earnings Date | Nov 5, 2026 |
| Ask | 2.07 |
| Volume | 591,819 |
| Avg. Volume (20D) | 1,144,782 |
| Open | 1.64 |
| Previous Close | 1.65 |
| Day's Range | 1.60 - 1.66 |
| 52-Week Range | 0.96 - 2.98 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About CDXS
Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeu...
Industry Biotechnology
Sector Healthcare
IPO Date Apr 22, 2010
Employees 146
Stock Exchange NasdaqGS
Ticker Symbol CDXS
Website https://www.codexis.com
Financial Performance
In 2025, Codexis's revenue was 70.39M, an increase of 18.61% compared to the previous year's 59.34M. Earnings were -43.97M, a decrease of -32.63%.
Financial StatementsEarnings Surprise
Codexis has released their quarterly earnings on Aug 11, 2026:
- Revenue of $15.25M misses estimates by $0, with 102.15% YoY growth.
- EPS of -0.13 misses estimates by -0.01, with 18.75% YoY growth.
Codexis Inc. is scheduled to release its earnings on Nov 5, 2026, during market hours.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2